These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 38053806)

  • 41. Compendial issues: WHO.
    Kopp-Kubel S
    J Parenter Sci Technol; 1992; 46(6):201-5. PubMed ID: 1474431
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Nomenclature and traceability debate for biosimilars: small-molecule surrogates lend support for distinguishable nonproprietary names.
    Chao J; Skup M; Alexander E; Tundia N; Macaulay D; Wu E; Mulani P
    Adv Ther; 2015 Mar; 32(3):270-83. PubMed ID: 25772256
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Catalog to families, genera, and species of orders Actiniaria and Corallimorpharia (Cnidaria: Anthozoa).
    Fautin DG
    Zootaxa; 2016 Aug; 4145(1):1-449. PubMed ID: 27515599
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Prescribe and advise freely].
    Revue Prescrire
    Med Trop (Mars); 2006 Dec; 66(6):577-80. PubMed ID: 17286025
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Assessment of pharmacists' views on biosimilar naming conventions.
    Fernandez-Lopez S; Kazzaz D; Bashir M; McLaughlin T
    J Manag Care Spec Pharm; 2015 Mar; 21(3):188-95. PubMed ID: 25726028
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [The information potential of the names of drugs].
    Springer V; Kolár J; Chalabala M
    Vnitr Lek; 2004 Feb; 50(2):91-7. PubMed ID: 15077580
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Using trade names: a risk factor for accidental drug overdose.
    Schwab M; Oetzel C; Mörike K; Jägle C; Gleiter CH; Eichelbaum M
    Arch Intern Med; 2002 May; 162(9):1065-6. PubMed ID: 11996619
    [TBL] [Abstract][Full Text] [Related]  

  • 48. What's in a name? Generics and the persistence of the pharmaceutical brand in American medicine.
    Greene JA
    J Hist Med Allied Sci; 2011 Oct; 66(4):468-506. PubMed ID: 20858701
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Detection and prediction limits for identifying highly confusable drug names from experimental data.
    Lambert BL; Bhaumik R; Zhao W; Bhaumik DK
    J Biopharm Stat; 2016; 26(2):365-85. PubMed ID: 26011079
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Generic drugs and legal incentives: which impact?].
    Livio F; Buclin T; Pannatier A; Biollaz J
    Rev Med Suisse; 2006 Apr; 2(61):966-9. PubMed ID: 16686328
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Drug name recognition and classification in biomedical texts. A case study outlining approaches underpinning automated systems.
    Segura-Bedmar I; Martínez P; Segura-Bedmar M
    Drug Discov Today; 2008 Sep; 13(17-18):816-23. PubMed ID: 18602492
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Generic drug names and social welfare.
    Lobo F; Feldman R
    J Health Polit Policy Law; 2013 Jun; 38(3):573-97. PubMed ID: 23418366
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [The similarity of drug names as a possible cause of confusion: Analysis of data from outpatient care].
    Schrader T; Tetzlaff L; Beck E; Mindt S; Geiss F; Hauser K; Franken C
    Z Evid Fortbild Qual Gesundhwes; 2020 Apr; 150-152():29-37. PubMed ID: 32279980
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Attitudes of physicians and pharmacists towards International Non-proprietary Name prescribing in Belgium.
    Van Bever E; Elseviers M; Plovie M; Vandeputte L; Van Bortel L; Vander Stichele R
    Basic Clin Pharmacol Toxicol; 2015 Mar; 116(3):264-72. PubMed ID: 25155133
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Drug packaging. A key factor to be taken into account when choosing a treatment.
    Prescrire Int; 2011 Oct; 20(120):247-9. PubMed ID: 21970097
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Name-changes in post-war France: the traumatic experiences of the Shoah and its consequences on the second and third generation with reference to the example of name-changes.
    Masson C
    Int J Psychoanal; 2013 Feb; 94(1):49-65. PubMed ID: 23438984
    [TBL] [Abstract][Full Text] [Related]  

  • 57. What's in a Name? Interlocutors Dynamically Update Expectations about Shared Names.
    Gegg-Harrison WM; Tanenhaus MK
    Front Psychol; 2016; 7():212. PubMed ID: 26955361
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A Method of Addressing Proprietary Name Similarity for US Prescription Drugs.
    Stockbridge MD; Taylor K
    Ther Innov Regul Sci; 2015 Jul; 49(4):524-529. PubMed ID: 30222425
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Xmas (brand substitution not permitted).
    Bromley J; Buckley NA
    Med J Aust; 2006 Dec 4-18; 185(11-12):687. PubMed ID: 17193726
    [TBL] [Abstract][Full Text] [Related]  

  • 60. USAN assigned to radioactive pharmaceutical.
    JAMA; 1976 Jan; 235(3):296. PubMed ID: 946053
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.